Skip to main content
Premium Trial:

Request an Annual Quote

Short-Term Incentive

Citing Forbes contributor Jim Golden's take on genomics in clinical oncology, Mike the Mad Biologist says microbial genomics will become more profitable than human genomics over the short term. "Microbial genomes are cheap, fast, and you can provide epidemiological relevant information to clinical laboratories, hospital networks, and public health departments," Mike says, later adding, "in two or three years, I don't see any technical hurdles to routine microbiological surveillance in hospitals." By comparison, human genomes are costly, take considerably longer, and do not necessarily yield clinically actionable information, Mike notes.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.